Population‐based estimate of the use of intermittent androgen deprivation therapy in prostate cancer patients in Catalonia, Spain
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4744
Abstract: To estimate the use of intermittent androgen deprivation (IAD) therapy in patients with prostate cancer (PCa). read more here.
Keywords: intermittent androgen; prostate cancer; use intermittent; estimate use ... See more keywords
The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.81
Abstract: 81Background: Intermittent hormone manipulation in castrate-sensitive prostate cancer can improve quality of life whilst maintaining comparable disease outcomes with continuous scheduling. Enzaluta... read more here.
Keywords: castrate; use intermittent; intermittent enzalutamide; prostate cancer ... See more keywords